Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017

Details for Mechanism ID: 18347
Country/Region: Angola
Year: 2017
Main Partner: Population Services International
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $3,217,557 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $321,756
Care: Pediatric Care and Support (PDCS) $0
Strategic Information (HVSI) $643,511
Health Systems Strengthening (OHSS) $0
Testing: HIV Testing and Counseling (HVCT) $836,565
Treatment: Adult Treatment (HTXS) $1,254,847
Treatment: Pediatric Treatment (PDTX) $160,878
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 43,845
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 132
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 2,740
HTS_TST Service Delivery Point Agg Age (Facility) ANC: <15, Negative 2018 1,399
HTS_TST Service Delivery Point Agg Age (Facility) ANC: 15+, Negative 2018 4,197
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 79
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 75
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 1,388
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 585
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Negative 2018 23
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Negative 2018 32
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 617
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 200
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Negative 2018 1,230
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Negative 2018 1,211
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 7,816
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 3,272
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Female, Negative 2018 38
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Male, Negative 2018 39
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Female, Negative 2018 300
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Male, Negative 2018 165
HTS_TST Service Delivery Point Agg Age (Facility) VCT: <15, Female, Negative 2018 759
HTS_TST Service Delivery Point Agg Age (Facility) VCT: <15, Male, Negative 2018 198
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Negative 2018 8,191
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Negative 2018 3,316
HTS_TST Sum of Test Result disaggregates 2018 5,843
HTS_TST_POS By Test Result: Positive 2018 5,843
HTS_TST_POS Service Delivery Point (Facility) Malnutrition: Positive 2018 22
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 470
HTS_TST_POS Service Delivery Point Agg Age (Facility) ANC: <15, Positive 2018 43
HTS_TST_POS Service Delivery Point Agg Age (Facility) ANC: 15+, Positive 2018 129
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 42
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 42
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 749
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 316
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Positive 2018 6
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 154
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 50
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Positive 2018 211
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Positive 2018 207
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 1,336
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 559
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: <15, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: <15, Male, Positive 2018 8
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Female, Positive 2018 57
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Male, Positive 2018 31
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: <15, Female, Positive 2018 114
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: <15, Male, Positive 2018 15
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Positive 2018 1,124
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Positive 2018 146
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 65
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 228
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 77
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 303
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 750
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 673
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 73
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 254
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 87
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 336
TB_PREV By Age/Sex (Numerator): <15, Female 2018 123
TB_PREV By Age/Sex (Numerator): <15, Male 2018 76
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 1,246
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 509
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 1,954
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 2,836
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 177
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 112
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 1,808
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 739
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 413
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,366
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 415
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,811
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 4,005
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 4,682
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 426
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,430
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 486
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 2,340
TX_CURR Aggregated Age/Sex: <15 Female 2018 1,299
TX_CURR Aggregated Age/Sex: <15 Male 2018 1,057
TX_CURR Aggregated Age/Sex: 15+ Female 2018 14,125
TX_CURR Aggregated Age/Sex: 15+ Male 2018 5,522
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 22,003
TX_CURR Sum of Aggregated Age/Sex <15 2018 2,356
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 19,647
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 22,003
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 812
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 826
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 4,137
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 1,768
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 7,543
TX_NEW Pregnancy status 2018 50
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 7,543
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 11,513
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 9,206
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 488
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 464
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 5,525
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 2,729
TX_PVLS Numerator: Indication: Routine 2018 9,206
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 50
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 611
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 580
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 6,908
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 3,414
TX_PVLS_den Denominator: Indication: Routine 2018 11,513
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 63
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 225
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 219
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,530
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,053
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 4,027
TX_RET Numerator by Status: Pregnant 2018 259
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 5,035
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 281
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 272
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 3,164
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,318
TX_RET_den Denominator by Status: Pregnant 2018 323
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 18,615
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 918
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 57
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 36
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 585
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 240
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 811
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 659
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 12,290
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 4,855
Cross Cutting Budget Categories and Known Amounts Total: $200,000
Gender: Gender Equality $200,000
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Capacity building
Changing harmful gender norms and promoting positive gender norms